It has been suggested that there is a reduced immunosuppressive function of Tregs due to impaired IL-2 signalling in T1D (24–28), a defect which may subsequently lead to a more aggressive immune destruction of pancreatic β cells by TEFF (12, 28). This evidence concerns the gene IL2 and type 1 diabetes mellitus.